Patrick Eldin

Dr. Patrick Eldin

IRIM, CNRS, Paris, Île-de-France, France
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
HVHenri J. Vial
Henri J. Vial
Patrick EldinPatrick Eldin
Patrick Eldin
ATAloysius G.M. Tielens
Aloysius G.M. Tielens
JHJaap J. van Hellemond
Jaap J. van Hellemond

1 March 2009 in Journal of General Virology
Verified
Journal Article
Open access
PDF file
Patrick EldinPatrick Eldin
Patrick Eldin
LPLaura Papon
Laura Papon
AOAlexandra Oteiza
Alexandra Oteiza
EBEmiliana Brocchi
Emiliana Brocchi
TLT. Glen Lawson
T. Glen Lawson
NMNadir Mechti
Nadir Mechti
The interferon (IFN) system is a major effector of the innate immunity that allows time for the subsequent establishment of an adaptive immune response against a wide-range of pathogens. Their diverse biological actions are thought to be mediated by the products of specific but usually overlapping sets of cellular genes induced in the target cells. Ubiquitin ligase members of the tripartite motif (TRIM) protein family have emerged as IFN-induced proteins involved in both innate and adaptive immunity. In this report, we provide evidence that TRIM22 is a functional E3 ubiquitin ligase that is also ubiquitinated itself. We demonstrate that TRIM22 expression leads to a viral protection of HeLa cells against encephalomyocarditis virus infections. This effect is dependent upon its E3 ubiquitinating activity, since no antiviral effect was observed in cells expressing a TRIM22-deletion mutant defective in ubiquitinating activity. Consistent with this, TRIM22 interacts with the viral 3C protease (3CPRO) and mediates its ubiquitination. Altogether, our findings demonstrate that TRIM22 E3 ubiquitin ligase activity represents a new antiviral pathway induced by IFN against picornaviruses.

1 June 2007 in Biochimie
Verified
Journal Article
Closed access
GDGenevieve Degols
Genevieve Degols
Patrick EldinPatrick Eldin
Patrick Eldin
NMNadir Mechti
Nadir Mechti

1 February 1997 in Journal of Immunological Methods
Verified
Journal Article
Closed access
Patrick EldinPatrick Eldin
Patrick Eldin
MPMary E Pauza
Mary E Pauza
YHYoko Hieda
Yoko Hieda
GLGaofeng Lin
Gaofeng Lin
MMMichael P Murtaugh
Michael P Murtaugh
CPChristopher A Pennell
Christopher A Pennell

15 February 2019 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
RMRoy Matkovic
Roy Matkovic
EBEric Bernard
Eric Bernard
SFSimon Fontanel
Simon Fontanel
Patrick EldinPatrick Eldin
Patrick Eldin
NCNathalie Chazal
Nathalie Chazal
LBLaurence BRIANT
Laurence BRIANT
The reemergence of chikungunya virus (CHIKV), an alphavirus that is transmitted to humans by Aedes mosquitoes, is a serious global health threat. In the absence of effective antiviral drugs, CHIKV infection has a significant impact on human health, with chronic arthritis being one of the most serious complications. The molecular understanding of host-virus interactions is a prerequisite to the development of targeted therapeutics capable to interrupt viral replication and transmission. Here, we identify the host cell DHX9 DExH-Box helicase as an essential cofactor for early CHIKV genome translation. We demonstrate that CHIKV nsP3 protein acts as a key factor for DHX9 recruitment to replication complexes. Finally, we establish that DHX9 behaves as a switch that regulates the progression of the viral cycle from translation to genome replication. This study might therefore have a significant impact on the development of antiviral strategies.

2 March 2006 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
LELucile Espert
Lucile Espert
Patrick EldinPatrick Eldin
Patrick Eldin
CGCeline Gongora
Celine Gongora
BBBernard Bayard
Bernard Bayard
FHFrancis Harper
Francis Harper
NMNadir Mechti
Nadir Mechti